Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis
| Errataetall: |
CommentOn: Osteoporos Int. 2022 Jun;33(6):1265-1273. - PMID 35059774 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:33 |
|---|---|
| Enthalten in: |
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA - 33(2022), 11 vom: 01. Nov., Seite 2441-2443 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ebina, Kosuke [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
3VHF2ZD92J |
|---|
| Anmerkungen: |
Date Completed 18.10.2022 Date Revised 27.10.2022 published: Print-Electronic CommentOn: Osteoporos Int. 2022 Jun;33(6):1265-1273. - PMID 35059774 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00198-022-06545-1 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34583741X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34583741X | ||
| 003 | DE-627 | ||
| 005 | 20231226030002.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00198-022-06545-1 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1152.xml |
| 035 | |a (DE-627)NLM34583741X | ||
| 035 | |a (NLM)36066579 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ebina, Kosuke |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Impact of the duration of previous osteoporosis treatment on the effect of romosozumab in patients with postmenopausal osteoporosis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.10.2022 | ||
| 500 | |a Date Revised 27.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Osteoporos Int. 2022 Jun;33(6):1265-1273. - PMID 35059774 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Bone Density Conservation Agents |2 NLM | |
| 650 | 7 | |a romosozumab |2 NLM | |
| 650 | 7 | |a 3VHF2ZD92J |2 NLM | |
| 700 | 1 | |a Etani, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuboi, Hideki |e verfasserin |4 aut | |
| 700 | 1 | |a Nagayama, Yoshio |e verfasserin |4 aut | |
| 700 | 1 | |a Kashii, Masafumi |e verfasserin |4 aut | |
| 700 | 1 | |a Miyama, Akira |e verfasserin |4 aut | |
| 700 | 1 | |a Kunugiza, Yasuo |e verfasserin |4 aut | |
| 700 | 1 | |a Hirao, Makoto |e verfasserin |4 aut | |
| 700 | 1 | |a Okamura, Gensuke |e verfasserin |4 aut | |
| 700 | 1 | |a Noguchi, Takaaki |e verfasserin |4 aut | |
| 700 | 1 | |a Takami, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Goshima, Atsushi |e verfasserin |4 aut | |
| 700 | 1 | |a Miura, Taihei |e verfasserin |4 aut | |
| 700 | 1 | |a Fukuda, Yuji |e verfasserin |4 aut | |
| 700 | 1 | |a Kurihara, Takuya |e verfasserin |4 aut | |
| 700 | 1 | |a Okada, Seiji |e verfasserin |4 aut | |
| 700 | 1 | |a Nakata, Ken |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA |d 1996 |g 33(2022), 11 vom: 01. Nov., Seite 2441-2443 |w (DE-627)NLM013671383 |x 1433-2965 |7 nnns |
| 773 | 1 | 8 | |g volume:33 |g year:2022 |g number:11 |g day:01 |g month:11 |g pages:2441-2443 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00198-022-06545-1 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 33 |j 2022 |e 11 |b 01 |c 11 |h 2441-2443 | ||